» Articles » PMID: 32489794

Prevalence and Correlates of Cardiovascular Autonomic Neuropathy Among Patients with Diabetes in Uganda: A Hospital-Based Cross-sectional Study

Overview
Journal Glob Heart
Publisher Ubiquity Press
Date 2020 Jun 4
PMID 32489794
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cardiovascular autonomic neuropathy (CAN) is a common complication in individuals with diabetes mellitus (DM) but often overlooked in clinical practice. The burden and correlates of CAN have not been extensively studied in low-income countries, particularly in sub-Saharan Africa.

Objectives: To determine the prevalence and correlates of CAN among adults in ambulatory diabetes care in southwestern Uganda.

Method: We conducted a cross-sectional study among adults with diabetes from November 2018 to April 2019. CAN was assessed using the five autonomic function tests: deep breathing, Valsalva maneuver, postural index on standing, change in blood pressure during standing and diastolic blood pressure response to isometric exercise. We estimated the prevalence of CAN and fit regression models to identify its demographic and clinical correlates.

Results: We enrolled 299 individuals. The mean age was 50.1 years (SD ± 9.8), mean HbA1c was 9.7 (SD ± 2.6) and 69.6% were female. CAN was detected in 156/299 (52.2%) of the participants on the basis of one or more abnormal cardiovascular autonomic reflex tests. Out of 299 participants, 88 (29.4%) were classified as early CAN while 61/299 (20.4%) and 7/299 (2.3%) were classified as definite and severe (advanced) CAN respectively. In multivariable regression models, age over 50 years (aOR 3.48, 95%CI 1.35 -8.99, p = 0.010), duration of diabetes over 10 years (aOR 4.09, 95%CI 1.78 -9.38, p = 0.001), and presence of diabetic retinopathy (aOR 2.25, 95%CI 1.16 -4.34, p = 0.016) were correlated with CAN.

Conclusions: Our findings reveal a high prevalence of CAN among individuals in routine outpatient care for diabetes mellitus in Uganda. Older age, longer duration of diabetes and coexistence of retinopathy are associated with CAN. Future work should explore the clinical significance and long term outcomes associated with CAN in this region.

Citing Articles

Evaluating treatment options for cardiovascular autonomic neuropathy in patients with diabetes mellitus: a systematic review.

Goh J, Koh L Diabetol Int. 2023; 14(3):224-242.

PMID: 37397902 PMC: 10307756. DOI: 10.1007/s13340-023-00629-x.


High prevalence of prolonged QTc interval among individuals in ambulatory diabetic care in southwestern Uganda.

Migisha R, Agaba D, Katamba G, Miranda S, Muyingo A, Siedner M Int J Diabetes Dev Ctries. 2022; 41(4):614-620.

PMID: 35177883 PMC: 8849522. DOI: 10.1007/s13410-021-00944-6.


Mbarara University Research Training Initiative: Experiences and Accomplishments of the MEPI Junior D43 TW010128 Award in Uganda.

Wakida E, Atuhaire C, Karungi C, Maling S, Obua C Adv Med Educ Pract. 2021; 12:1397-1410.

PMID: 34887692 PMC: 8650769. DOI: 10.2147/AMEP.S339752.


High prevalence of uncontrolled hypertension among patients with type 2 diabetes mellitus: a hospital-based cross-sectional study in Southwestern Uganda.

Saasita P, Senoga S, Muhongya K, Agaba D, Migisha R Pan Afr Med J. 2021; 39:142.

PMID: 34527158 PMC: 8418183. DOI: 10.11604/pamj.2021.39.142.28620.


Cardiovascular autonomic neuropathy in diabetes: Pathophysiology, clinical assessment and implications.

Duque A, Mediano M, De Lorenzo A, Rodrigues Jr L World J Diabetes. 2021; 12(6):855-867.

PMID: 34168733 PMC: 8192252. DOI: 10.4239/wjd.v12.i6.855.


References
1.
Witte D, Tesfaye S, Chaturvedi N, Eaton S, Kempler P, Fuller J . Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia. 2004; 48(1):164-71. DOI: 10.1007/s00125-004-1617-y. View

2.
Ratzmann K, Raschke M, Gander I, Schimke E . Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (noninsulin-dependent) diabetes. J Diabet Complications. 1991; 5(1):1-5. DOI: 10.1016/0891-6632(91)90002-7. View

3.
Valensi P, Johnson N, Maison-Blanche P, Extramania F, Motte G, Coumel P . Influence of cardiac autonomic neuropathy on heart rate dependence of ventricular repolarization in diabetic patients. Diabetes Care. 2002; 25(5):918-23. DOI: 10.2337/diacare.25.5.918. View

4.
Bonnemeier H, Richardt G, Potratz J, Wiegand U, Brandes A, Kluge N . Circadian profile of cardiac autonomic nervous modulation in healthy subjects: differing effects of aging and gender on heart rate variability. J Cardiovasc Electrophysiol. 2003; 14(8):791-9. DOI: 10.1046/j.1540-8167.2003.03078.x. View

5.
Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R . Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011; 27(7):639-53. DOI: 10.1002/dmrr.1239. View